文献速递疼痛医学神经外科与老年麻醉

肠道菌群通过调节促炎与抗炎T细胞影响神经病理性疼痛

Gut Microbiota Influences Neuropathic Pain Through Modulating Proinflammatory and Anti-inflammatory T Cells.
PubMed 文献 · Anesth Analg · 2021-01-01

该研究在小鼠慢性坐骨神经缩窄伤(CCI)模型中,用广谱口服抗生素扰动肠道菌群,发现抗生素减轻了机械性痛觉超敏和热痛觉过敏,脊髓Th1细胞比例降低而Foxp3+调节性T细胞比例升高;耗竭调节性T细胞可逆转抗生素的镇痛保护作用,并伴随脊髓Th1细胞浸润显著增加。结论认为肠道菌群通过调节促炎与抗炎T细胞部分介导CCI神经病理性疼痛。

要点

  • 口服广谱抗生素改变肠道菌群可减轻CCI小鼠的机械性痛觉超敏和热痛觉过敏。
  • 抗生素组脊髓Th1细胞比例降低、Foxp3+调节性T细胞比例升高,免疫表型向抗炎偏移。
  • 耗竭Foxp3+调节性T细胞可逆转菌群改变带来的镇痛保护,并增加脊髓Th1细胞浸润。

核心结论

  • 肠道菌群在CCI神经病理性疼痛中起关键作用,该作用部分通过调节促炎与抗炎T细胞介导。

研究设计与样本

  • 小鼠CCI神经病理性疼痛模型研究,使用广谱口服抗生素混合剂扰动肠道菌群,并采用Foxp3-GFP-DTR敲入小鼠模型实现调节性T细胞的定点耗竭。

主要发现

  • 口服抗生素诱导肠道菌群改变并减轻CCI后机械性痛觉超敏和热痛觉过敏。
  • 抗生素组Th1细胞百分比均值1.0(95%CI 0.9-1.2),低于饮水组均值8.4(95%CI 7.8-9.0),P<.01,Cohen's d=18.8。
  • 抗生素组Foxp3+调节性T细胞百分比均值8.1(95%CI 6.8-9.3),高于饮水组均值2.8(95%CI 2.2-3.3),P<.01,Cohen's d=6.2。
  • 耗竭Foxp3+调节性T细胞后脊髓Th1细胞浸润由耗竭前均值2.8%(95%CI 2.2-3.5)升至耗竭后均值9.1%(95%CI 7.2-11.0),p<.01,Cohen's d=5.0。

临床怎么用

  • 动物实验提示肠道菌群状态可能影响神经病理性疼痛的免疫机制,围术期或疼痛诊疗中应关注抗菌药物使用与菌群扰动对疼痛转归的潜在影响。
  • 调节性T细胞与Th1细胞的平衡是菌群影响神经病理性疼痛的潜在中间环节,但目前仅为小鼠模型证据,尚不能直接转化为临床干预。

局限性

  • 研究为小鼠CCI模型,结论外推至人类神经病理性疼痛需谨慎。
  • 采用广谱口服抗生素混合剂扰动菌群,未明确具体菌种或代谢通路。
  • 原文摘要未报告样本量及盲法等具体实验设计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gut microbiota, a consortium of diverse microorganisms residing in the gastrointestinal tract, has emerged as a key player in neuroinflammatory responses, supporting the functional relevance of the "gut-brain axis." Chronic-constriction injury of the sciatic nerve (CCI) is a commonly used animal model of neuropathic pain with a major input from T cell-mediated immune responses. In this article, we sought to examine whether gut microbiota influences CCI neuropathic pain, and, if so, whether T-cell immune responses are implicated. METHODS: We used a mixture of wide-spectrum oral antibiotics to perturbate gut microbiota in mice and then performed CCI in these animals. Nociceptive behaviors, including mechanical allodynia and thermal hyperalgesia, were examined before and after CCI. Additionally, we characterized the spinal cord infiltrating T cells by examining interferon (IFN)-γ, interleukin (IL)-17, and Foxp3. Using a Foxp3-GFP-DTR "knock-in" mouse model that allows punctual depletion of regulatory T cells, we interrogated the role of these cells in mediating the effects of gut microbiota in the context of CCI neuropathic pain. RESULTS: We found that oral antibiotics induced gut microbiota changes and attenuated the development of CCI neuropathic pain, as demonstrated by dampened mechanical allodynia and thermal hyperalgesia. Percentages of IFN-γ-producing Th1 cells and Foxp3+ regulatory T cells were significantly different between animals that received oral antibiotics (Th1 mean = 1.0, 95% confidence interval [CI], 0.9-1.2; Foxp3 mean = 8.1, 95% CI, 6.8-9.3) and those that received regular water (Th1 mean = 8.4, 95% CI, 7.8-9.0, P < .01 oral antibiotics versus water, Cohen's d = 18.8; Foxp 3 mean = 2.8, 95% CI, 2.2-3.3, P < .01 oral antibiotics versus water, Cohen's d = 6.2). These T cells characterized a skewing from a proinflammatory to an anti-inflammatory immune profile induced by gut microbiota changes. Moreover, we depleted Foxp3+ regulatory T cells and found that their depletion reversed the protection of neuropathic pain mediated by gut microbiota changes, along with a dramatic increase of IFN-γ-producing Th1 cell infiltration in the spinal cord (before depletion mean = 2.8%, 95% CI, 2.2-3.5; after depletion mean = 9.1%, 95% CI, 7.2-11.0, p < .01 before versus after, Cohen's d = 5.0). CONCLUSIONS: Gut microbiota plays a critical role in CCI neuropathic pain. This role is mediated, in part, through modulating proinflammatory and anti-inflammatory T cells.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Ding W, You Z, Chen Q, et al. Gut Microbiota Influences Neuropathic Pain Through Modulating Proinflammatory and Anti-inflammatory T Cells. Anesth Analg. 2021. PMID: 32889847. doi:10.1213/ANE.0000000000005155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。